How and Why to Organize Family-Based Screening Clinics for Hypertrophic Cardiomyopathy.
Journal
The Canadian journal of cardiology
ISSN: 1916-7075
Titre abrégé: Can J Cardiol
Pays: England
ID NLM: 8510280
Informations de publication
Date de publication:
02 Oct 2023
02 Oct 2023
Historique:
received:
23
08
2023
revised:
20
09
2023
accepted:
27
09
2023
medline:
5
10
2023
pubmed:
5
10
2023
entrez:
4
10
2023
Statut:
aheadofprint
Résumé
Hypertrophic cardiomyopathy (HCM) is a common, genetically heterogeneous inherited heart condition most frequently associated with pathogenic variants in genes encoding the cardiac sarcomere. Identifying at-risk relatives through cardiovascular screening and cascade genetic testing promotes early diagnosis and enables personalized management. Multispecialty expertise is required to efficiently and effectively engage HCM families in this process. Initial assessments include clinical evaluation, cardiac imaging, family history analysis, and genetic testing/counseling. These elements are optimally combined in a multidisciplinary family-based clinic which facilitates coordinated management and family support. Here we describe the rationale for, and components of, a multidisciplinary family-based HCM screening clinic.
Identifiants
pubmed: 37793569
pii: S0828-282X(23)01744-0
doi: 10.1016/j.cjca.2023.09.027
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
Copyright © 2023. Published by Elsevier Inc.